REQUEST A DEMO
Total
USD $0.00
Search more companies

Adexa Pharma Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Adexa Pharma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Adexa Pharma Sas is based in Colombia. The head office is in Bogota D.C.. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on October 07, 2010. 10 (2024) employees currently work for Adexa Pharma Sas. From the latest financial highlights, Adexa Pharma Sas reported a net sales revenue increase of 91.06% in 2023. A growth of 38.74% was recorded in its total assets. The net profit margin of Adexa Pharma Sas decreased by 0.86% in 2023.

Headquarters
Ac 24 No 95 A 80 T2 Of 610 Edificio Colfecar
Bogota D.C.; Bogota D.C; Postal Code: 0703

Contact Details: Purchase the Adexa Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Adexa Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Adexa Pharma Sas report to view the information.
Incorporation Date:
October 07, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Adexa Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
91.06%
Total operating revenue
91.06%
Operating profit (EBIT)
61.95%
Net Profit (Loss) for the Period
61.95%
Total assets
38.74%
Total equity
22.4%
Operating Profit Margin (ROS)
-1.32%
Net Profit Margin
-0.86%
Return on Equity (ROE)
4.32%
Quick Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?